MyLam
Lam Research Corporation Announces Fourth Quarter And Year-End 1999 Results
July 29, 1999

Lam Research Corporation Announces Fourth Quarter And Year-End 1999 Results

FREMONT, Calif. - July 29, 1999 - Lam Research Corporation (Nasdaq: LRCX ), a leading supplier of wafer fabrication equipment and services to the worldwide semiconductor industry, today announced financial results for the periods ended June 30, 1999.

Revenues of $210.9 million for the fourth quarter increased sequentially by 38 percent and generated net income of $11.3 million, or $0.28 per share. This compares with revenues of $230.6 million and a net loss of $1.9 million, or $0.05 per share (excluding restructuring charges of $64.0 million, $1.67 per share) for the quarter ended June 30, 1998. Revenues increased in all regions and particularly in Asia Pacific. Geographic revenue distribution for the quarter was: North America, 38 percent; Europe, 16 percent; Japan, 7 percent; and Asia Pacific, 39 percent.

For the 12 months ended June 30, 1999, the company reported a net loss of $54.5 million or $1.42 per share on revenues of $648 million compared to an after tax loss of $0.3 million ($0.01 per share) on revenues of $1.05 billion for the previous fiscal year. These amounts exclude after tax restructuring and other non-recurring charges of $58.4 million ($1.51 per share) and $144.3 million ($3.79 per share) for fiscal years 1999 and 1998, respectively.

New orders for the quarter were up sequentially, resulting in a book to bill ratio in excess of 1.2 to 1. Geographic distribution of orders during the June quarter was: North America, 32 percent; Europe, 25 percent; Japan, 14 percent; and Asia Pacific, 29 percent.

Gross margins increased to 38.8 percent during the period from 35.5 percent in March 1999, the result of economies of scale in manufacturing and reductions in materials costs. Continued focus on cost management and administrative efficiencies drove operating expenses as a percentage of revenue significantly lower than the previous quarter.

Lam’s balance sheet remains strong. Cash, short-term investments and restricted cash, increased by $18 million during the quarter and reached $372 million at June 30, 1999. Ongoing emphasis on asset management resulted in positive cash flow from operations for the second consecutive quarter, as the Accounts Receivable Days Sales Outstanding (DSO) ratio fell to 74 days and inventory management yielded substantially improved turnover performance.

“This quarter marks the company’s return to profitability and we are very pleased with the progress we have made. In particular, we have significantly strengthened our etch market position and in early June, successfully launched the ExelanTM dielectric etch system. We have penetrated the CMP market with our TeresTM system which is exceeding industry technology and reliability standards,” stated James W. Bagley, chairman and chief executive officer of Lam. “Our product and customer support capability, combined with the improving industry fundamentals should allow the company to further benefit from the opportunities ahead,” Bagley concluded.

This press release contains certain forward-looking statements which are subject to the Safe Harbor provisions created by the Private Securities Litigation Reform Act of 1995. Such forward-looking statements relate to the prospective demand for the company’s products, acceptance and competitiveness of the company’s products and market transition to new processes. Such statements are based on current expectations and are subject to risks, uncertainties, and changes in condition and other risks detailed in documents filed with the Securities and Exchange Commission, including specifically the report on Form 10-K for the year ended June 30, 1998, and the Form 10-Q/A for the quarter ended March 31, 1999. The company undertakes no obligation to update the information in this press release.

Lam Research Corporation is a leading supplier of wafer fabrication equipment and services to the world’s semiconductor industry. The company’s common stock trades on the Nasdaq National Securities Market under the symbol “LRCX.”



 

LAM RESEARCH CORPORATION CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
(In thousands, except per share data)
(Unaudited)

 












 

        Three Months Ended
June 30,
  Twelve Months Ended
June 30,
     
1999
 
1998
 
1999
 
1998
Total revenue     $ 210,885   $ 230,586   $ 647,955   $ 1,052,586
Cost and expenses:                
  Cost of goods sold- on net sales   129,071   138,135   414,591   646,511
  Cost of goods sold - restructuring charges   -
  12,380
  -
  31,933
  Gross margin   81,814   80,071   233,364   374,142
 
  Research and development 37,638   48,949   142,495   206,456
  Selling, general and administrative 33,109   47,704   145,698   201,900
  Restructuring charges   -   51,582   53,372   116,925
  Merger costs   -   -   -   17,685
  Acquired in-preocess research & development   -   -   5,000   12,100
   
Operating income (loss)

11,067
 
(68,164)
 
(113,201)
 
(180,924)
 
Other income, net   282   1,458   288   1,799
 

Income (loss) before income taxes

11,349
 
(66,706)
 
(112,913)
 
(179,125)
Income tax benefit   -   818   -   34,526

Net income (loss)
 
$ 11,349
 
$ (65,888)
 
$ (112,913)
 
$ (144,599)
Net income (loss) per share              
  Basic     $ 0.29   $ (1.72)   $ (2.93)   $ (3.80)
 
Diluted
   
$ 0.28
 
$&nbsp (1.72)
 
$ (2.93)
 
$ (3.80)
Number of shares used in per share calculation                
  Basic     38,495   38,250   38,492   38,057
 
Diluted
   
40,881
 
38,250
 
38,492
 
38,057
 

 

LAM RESEARCH CORPORATION CONDENSED CONSOLIDATED BALANCE SHEETS
(In thousands)
(Unaudited)

 
June 30, 1999
June 30, 1998
 

Assets:    
Cash and short-term investments
$ 311,801
$397,156
Accounts receivable, net
170,531
176,029
Inventories
183,716
220,610
Other current assets
72,822
103,294
 

Total current assets
738,870
897,089
     
Equipment/leasehold improvements, net
103,337
144,252
Restricted cash
60,348
51,357
Other assets
76,896
58,074
 

Total assets
$ 979,451
$ 1,150,772
 

Liabilities and stockholders’ equity:    
     
Total current liabilites
243,995
293,509
Long-term debt and other
326,500
334,174
Stockholders’ equity
408,956
523,089
     
 

Total liabilities and stockholders’ equity
$ 979,451
$ 1,150,772
 

 
circle-arrow2circle-arrow2facebookgooglehandshake2health2linkedinmenupdfplant2searchtwitteryoutube